Provided by Tiger Fintech (Singapore) Pte. Ltd.

Acurx Pharmaceuticals, LLC*

0.6025
+0.05259.55%
Post-market: 0.5880-0.0145-2.41%19:59 EDT
Volume:2.46M
Turnover:1.41M
Market Cap:14.15M
PE:-0.88
High:0.6320
Open:0.5500
Low:0.5192
Close:0.5500
Loading ...
Jun 18, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 02, 2024

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Mar 29, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Mar 18, 2024

Major Issues Report

Form 8-K - Current report
Mar 18, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Mar 15, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 15, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Nov 15, 2023

Major Issues Report

Form 8-K - Current report
Nov 15, 2023

Major Issues Report

Form 8-K - Current report
Nov 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2023

Major Issues Report

Form 8-K - Current report
Oct 02, 2023

Major Issues Report

Form 8-K - Current report
Aug 14, 2023

Major Issues Report

Form 8-K - Current report
Aug 11, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 06, 2023

Correspondence

Form CORRESP - Correspondence
Jun 30, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jun 21, 2023

Major Issues Report

Form 8-K - Current report